Azitra, Inc.

AZTR Biotech & pharma

Develops live biotherapeutic products for skin diseases.

Dec 2025Revenue $0.00/yrExpenses $11.0M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year

When will Azitra be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $11.0M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$0.00$11.0M−$11.0M
Dec 2024$7.50K$11.0M−$11.0M
Dec 2023$686K$8.14M−$7.45M
Dec 2022$284K$9.74M−$9.45M